Caption Management’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
VCM
VPM
Caption Management's BIIB Position: Q1 2026 in Review
Caption Management sold out of Biogen (BIIB) in Q1 2026, closing a stake of 53,000 shares — an estimated $9.77M sold.
Caption Management first reported a position in BIIB in Q4 2019 and held it in 15 quarters. The position peaked at $63.2M in Q3 2021. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.
- Caption Management reported no remaining Biogen position as of Q1 2026 after selling out during the quarter.
- Caption Management sold 53,000 Biogen shares in Q1 2026, an estimated $9.77M.
- Caption Management first reported a position in Biogen in Q4 2019 and held it in 15 quarters.
- Caption Management's Biogen position peaked at $63.2M in Q3 2021.
- 1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.
Based on Caption Management's 13F filing for Q1 2026, filed 15 May 2026.